Article Details
Retrieved on: 2022-08-03 20:30:37
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The San Diego company and Roche plan to develop allogeneic CAR-T therapies against targets in multiple myeloma, B-cell lymphomas and other hematologic ...
Article found on: www.morningstar.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here